These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3845880)

  • 1. Multiple risk factor intervention in coronary heart disease.
    Hjermann I
    Ciba Found Symp; 1985; 110():110-25. PubMed ID: 3845880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men.
    Hjermann I; Velve Byre K; Holme I; Leren P
    Lancet; 1981 Dec; 2(8259):1303-10. PubMed ID: 6118715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oslo Study Diet and Antismoking Trial. Results after 102 months.
    Hjermann I; Holme I; Leren P
    Am J Med; 1986 Feb; 80(2A):7-11. PubMed ID: 3511692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intervention of smoking and eating habits in healthy men carrying high risk for coronary heart disease. The Oslo Study.
    Hjermann I
    Acta Med Scand Suppl; 1981; 651():281-4. PubMed ID: 6948504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Oslo Study: diet and antismoking advice. Additional results from a 5-year primary preventive trial in middle-aged men.
    Holme I; Hjermann I; Helgeland A; Leren P
    Prev Med; 1985 May; 14(3):279-92. PubMed ID: 3903733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.
    JAMA; 1984 Jan; 251(3):351-64. PubMed ID: 6361299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
    Am J Cardiol; 1986 Jul; 58(1):1-13. PubMed ID: 2873741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in serum total cholesterol and risks of coronary events and cerebral infarction in Japanese men: the Kyushu Lipid Intervention Study.
    Sasaki J; Arakawa K; Iwashita M; Matsushita Y; Kono S;
    Circ J; 2003 Jun; 67(6):473-8. PubMed ID: 12808261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
    Rifkind BM
    Am J Cardiol; 1984 Aug; 54(5):30C-34C. PubMed ID: 6382999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of clinical trials: proving the lipid hypothesis.
    Brown WV
    Eur Heart J; 1990 Dec; 11 Suppl H():15-20. PubMed ID: 2073909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials.
    Cutler JA; Neaton JD; Hulley SB; Kuller L; Paul O; Stamler J
    Prev Med; 1985 May; 14(3):293-311. PubMed ID: 3903734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of coronary heart disease: some results from the Oslo secondary and primary intervention studies.
    Leren P
    J Am Coll Nutr; 1989 Oct; 8(5):407-10. PubMed ID: 2607071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Oslo study: CHD risk factors, socioeconomic influences, and intervention.
    Leren P; Helgeland A; Hjermann I; Holme I
    Am Heart J; 1983 Nov; 106(5 Pt 2):1200-6. PubMed ID: 6637785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS).
    Watts GF; Lewis B; Brunt JN; Lewis ES; Coltart DJ; Smith LD; Mann JI; Swan AV
    Lancet; 1992 Mar; 339(8793):563-9. PubMed ID: 1347091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Lipid Research Clinics Coronary Primary Prevention Trial.
    Rifkind BM
    Drugs; 1986; 31 Suppl 1():53-60. PubMed ID: 3720571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
    Sever PS; Dahlöf B; Poulter NR; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J;
    Lancet; 2003 Apr; 361(9364):1149-58. PubMed ID: 12686036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in coronary heart disease mortality and morbidity and related factors in Finland.
    Pyörälä K; Salonen JT; Valkonen T
    Cardiology; 1985; 72(1-2):35-51. PubMed ID: 2858266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for dietary and anti-smoking advice. Practical experiences from the Oslo Study.
    Hjermann I
    Drugs; 1988; 36 Suppl 3():105-9. PubMed ID: 2855516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dietary and antismoking advice on the incidence of myocardial infarction: a 16-year follow-up of the Oslo Diet and Antismoking Study after its close.
    Holme I; Haaheim LL; Tonstad S; Hjermann I
    Nutr Metab Cardiovasc Dis; 2006 Jul; 16(5):330-8. PubMed ID: 16829341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.